Alector (ALEC) Current Deferred Revenue (2018 - 2026)
Alector (ALEC) reported Current Deferred Revenue of $6.7 million for Q1 2026, down 69.23% year-over-year from $21.8 million in Q1 2025, and up 0.58% quarter-over-quarter from $6.7 million in Q4 2025.
Alector (ALEC) Current Deferred Revenue (2018 - 2026) Analysis & Trends
Alector (ALEC) has 9 years of Current Deferred Revenue data on file, last reported at $6.7 million in Q1 2026.
- Current Deferred Revenue for Q1 2026 came in at $6.7 million, down 69.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.7 million (down 69.23% YoY), and the FY2025 annual result was $6.7 million, down 71.75% from the prior year.
- Current Deferred Revenue advanced to $6.7 million in Q1 2026 per ALEC's latest filing, from $6.7 million in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $444.9 million in Q1 2022 and troughed at $454800.0 in Q3 2022.
- A 5-year average of $90.8 million and a median of $55.4 million in 2024 frame the typical range for Current Deferred Revenue.
- The sharpest annual moves came in 2022 and 2023: Current Deferred Revenue sank 99.86% in 2022, then surged 17613.5% in 2023.
- A 5-year view of Current Deferred Revenue shows it stood at $48.2 million in 2022, then soared by 72.04% to $83.0 million in 2023, then tumbled by 71.48% to $23.7 million in 2024, then tumbled by 71.75% to $6.7 million in 2025, then increased by 0.58% to $6.7 million in 2026.
- Business Quant data shows ALEC's Current Deferred Revenue at $6.7 million in Q1 2026, $6.7 million in Q4 2025, and $11.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Alector | 193.53 Mn | -12.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.72 Mn |
| Dec 31, 2025 | 6.68 Mn |
| Sep 30, 2025 | 11.74 Mn |
| Jun 30, 2025 | 13.40 Mn |
| Mar 31, 2025 | 21.85 Mn |
| Dec 31, 2024 | 23.66 Mn |
| Sep 30, 2024 | 55.43 Mn |
| Jun 30, 2024 | 63.96 Mn |
| Mar 31, 2024 | 73.35 Mn |
| Dec 31, 2023 | 82.98 Mn |
| Sep 30, 2023 | 80.56 Mn |
| Jun 30, 2023 | 68.55 Mn |
| Mar 31, 2023 | 433.60 Mn |
| Dec 31, 2022 | 48.23 Mn |
| Sep 30, 2022 | 454,800.00 |
| Jun 30, 2022 | 106.99 Mn |
| Mar 31, 2022 | 444.90 Mn |
| Dec 31, 2021 | 307.90 Mn |
| Sep 30, 2021 | 320.20 Mn |
| Jun 30, 2021 | 121.60 Mn |